| Product Code: ETC9961368 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States saw significant budesonide inhaler import shipments from top countries like India, Italy, Slovenia, Belgium, and Denmark. Despite the diversity of sources, the market concentration, as measured by HHI, remained low, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 11.26%, showcasing a growing demand for budesonide inhalers. However, there was a notable decline in growth rate from 2023 to 2024 at -32.38%, suggesting potential market fluctuations or shifts in consumer preferences.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Budesonide Inhaler Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Budesonide Inhaler Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Budesonide Inhaler Market - Industry Life Cycle |
3.4 United States (US) Budesonide Inhaler Market - Porter's Five Forces |
3.5 United States (US) Budesonide Inhaler Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Budesonide Inhaler Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 United States (US) Budesonide Inhaler Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.8 United States (US) Budesonide Inhaler Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Budesonide Inhaler Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Budesonide Inhaler Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases such as asthma and COPD in the United States |
4.2.2 Growing awareness about the benefits of using budesonide inhalers for managing respiratory conditions |
4.2.3 Technological advancements leading to the development of more efficient and user-friendly budesonide inhalers |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and marketing of budesonide inhalers |
4.3.2 Competition from alternative treatment options such as oral medications or other inhalers |
4.3.3 Potential side effects associated with the long-term use of budesonide inhalers |
5 United States (US) Budesonide Inhaler Market Trends |
6 United States (US) Budesonide Inhaler Market, By Types |
6.1 United States (US) Budesonide Inhaler Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Budesonide Inhaler Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Budesonide Inhaler Market Revenues & Volume, By Nebulizer, 2021- 2031F |
6.1.4 United States (US) Budesonide Inhaler Market Revenues & Volume, By Inhalants, 2021- 2031F |
6.2 United States (US) Budesonide Inhaler Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Budesonide Inhaler Market Revenues & Volume, By Dry Powder, 2021- 2031F |
6.2.3 United States (US) Budesonide Inhaler Market Revenues & Volume, By Spray, 2021- 2031F |
6.2.4 United States (US) Budesonide Inhaler Market Revenues & Volume, By Suspension, 2021- 2031F |
6.2.5 United States (US) Budesonide Inhaler Market Revenues & Volume, By Aerosols, 2021- 2031F |
6.3 United States (US) Budesonide Inhaler Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Budesonide Inhaler Market Revenues & Volume, By 0.25mg, 2021- 2031F |
6.3.3 United States (US) Budesonide Inhaler Market Revenues & Volume, By 0.5mg, 2021- 2031F |
6.3.4 United States (US) Budesonide Inhaler Market Revenues & Volume, By 1.0mg, 2021- 2031F |
6.4 United States (US) Budesonide Inhaler Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Budesonide Inhaler Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 United States (US) Budesonide Inhaler Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5 United States (US) Budesonide Inhaler Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Budesonide Inhaler Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Budesonide Inhaler Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 United States (US) Budesonide Inhaler Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 United States (US) Budesonide Inhaler Market Import-Export Trade Statistics |
7.1 United States (US) Budesonide Inhaler Market Export to Major Countries |
7.2 United States (US) Budesonide Inhaler Market Imports from Major Countries |
8 United States (US) Budesonide Inhaler Market Key Performance Indicators |
8.1 Patient adherence rate to budesonide inhaler therapy |
8.2 Number of prescriptions for budesonide inhalers |
8.3 Rate of hospitalizations due to uncontrolled respiratory conditions despite budesonide inhaler usage |
9 United States (US) Budesonide Inhaler Market - Opportunity Assessment |
9.1 United States (US) Budesonide Inhaler Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Budesonide Inhaler Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 United States (US) Budesonide Inhaler Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.4 United States (US) Budesonide Inhaler Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Budesonide Inhaler Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Budesonide Inhaler Market - Competitive Landscape |
10.1 United States (US) Budesonide Inhaler Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Budesonide Inhaler Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |